MedTrace Logo

Microbiome Analysis in esoPhageal, PancreatIc and Colorectal CaNcer Patients Undergoing Gastrointestinal Surgery

NCT04189393 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2019-12-06

No results posted yet for this study

Summary

The MA-PPING is a multicenter prospective observational study that includes patients undergoing surgery for gastrointestinal cancer.

The study aims to map the oral and gut microbiome of patients diagnosed with pancreatic, esophageal or colorectal cancer during their surgical patient journey from the moment of diagnosis until full recovery (three months after surgery).

Conditions

Sponsors & Collaborators

  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Stefan AW Bouwense, MD PhD · Radboud University Medical Center Nijmegen

  • Martijn WJ Stommel, MD PhD · Radboud University Medical Center Nijmegen

  • Harry van Goor, MD PhD · Radboud University Medical Center Nijmegen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2021-11-01
Completion
2021-11-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04189393 on ClinicalTrials.gov